Iketani Foundation for Science and Technology | JPY 3.0 million | June 2026\u2013May 2028<\/strong> Project Mirai | JPY 1.0 million | January 2026\u2013December 2026<\/strong> The Hitachi Global Foundation, Kurata Grants | JPY 1.0 million | January 2026\u2013December 2026<\/strong> Takeda Science Foundation (Continuing Grant) | JPY 2.0 million | April 2025\u2013March 2029<\/strong> Kobayashi Foundation for Cancer Research | JPY 5.0 million | June 2025\u2013May 2026<\/strong> Yamaguchi Endocrine Research Foundation | JPY 2.5 million | April 2025\u2013March 2026<\/strong> Takahashi Industrial and Economic Research Foundation | JPY 3.0 million | April 2023\u2013March 2026<\/strong> JSPS KAKENHI, Grant-in-Aid for Scientific Research (C) | JPY 3.0 million | April 2026\u2013March 2029<\/strong> JSPS KAKENHI, Grant-in-Aid for Scientific Research (C) | JPY 3.0 million | April 2026\u2013March 2029<\/strong> JSPS KAKENHI, Grant-in-Aid for Scientific Research (C) | JPY 4.55 million | April 2025\u2013March 2028<\/strong> JSPS KAKENHI, Grant-in-Aid for Scientific Research (C) | JPY 4.68 million | April 2024\u2013March 2027<\/strong> <\/p>\n\n\n\n Kobayashi Foundation | JPY 3.5 million | April 2024\u2013March 2026<\/strong> The Japan Endocrine Society, Young Investigator Research Grant | JPY 2.5 million | April 2025\u2013March 2026<\/strong> Nippon Shinyaku Research Grant | JPY 3.0 million | April 2025\u2013March 2026<\/strong> JSPS KAKENHI, Fund for the Promotion of Joint International Research (Fostering Joint International Research (B)) | JPY 20.0 million | October 2022\u2013March 2026<\/strong> JSPS KAKENHI, Grant-in-Aid for Scientific Research (C) | JPY 4.16 million | April 2022\u2013March 2025<\/strong> Suzuki Foundation for Urological Medicine | JPY 0.5 million | April 2024\u2013March 2025<\/strong> Yasumoto Tokumori Memorial Foundation for Tuberous Sclerosis Complex | JPY 2.0 million | April 2024\u2013March 2025<\/strong> JSPS KAKENHI, Grant-in-Aid for Scientific Research (C) | JPY 4.17 million | April 2022\u2013March 2025<\/strong> Takeda Science Foundation | JPY 2.0 million | April 2022\u2013March 2025<\/strong> Life Science Foundation of Japan | JPY 1.0 million | April 2023\u2013March 2025<\/strong> Prostate Research Foundation | JPY 1.0 million | March 2023\u2013March 2024<\/strong> Japanese Urological Association Young Research Grant | JPY 0.5 million | March 2023\u2013March 2024<\/strong> SGH Foundation | JPY 1.0 million | December 2022\u2013December 2023<\/strong> Kowa Life Science Foundation | JPY 1.0 million | December 2022\u2013December 2023<\/strong> JSPS KAKENHI, Grant-in-Aid for Early-Career Scientists | JPY 4.29 million | April 2020\u2013March 2022<\/strong> <\/p>\n","protected":false},"excerpt":{"rendered":" Ongoing Research Grants Iketani Foundation for Science and Technology | JPY 3.0 million | June 2026\u2013May 2028De […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":385,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"sns_share_botton_hide":"","vkExUnit_sns_title":"","_vk_print_noindex":"","sitemap_hide":"","vkExUnit_sitemap":"","_veu_custom_css":"","veu_display_promotion_alert":"","_exclude_from_list_pages":"","vkexunit_cta_each_option":"","vkExUnit_childPageIndex":"","vkExUnit_pageList_ancestor":"","vkExUnit_contact_enable":"","_lightning_design_setting":{"layout":"col-one-no-subsection"},"footnotes":""},"class_list":["post-424","page","type-page","status-publish","hentry"],"veu_head_title_object":{"title":"","add_site_title":""},"_links":{"self":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/epcrc\/wp-json\/wp\/v2\/pages\/424","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/epcrc\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/epcrc\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/epcrc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/epcrc\/wp-json\/wp\/v2\/comments?post=424"}],"version-history":[{"count":1,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/epcrc\/wp-json\/wp\/v2\/pages\/424\/revisions"}],"predecessor-version":[{"id":426,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/epcrc\/wp-json\/wp\/v2\/pages\/424\/revisions\/426"}],"up":[{"embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/epcrc\/wp-json\/wp\/v2\/pages\/385"}],"wp:attachment":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/epcrc\/wp-json\/wp\/v2\/media?parent=424"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Development of a PSMA-Targeted Tumor Vasculature Drug Discovery Platform through Medical\u2013Engineering Collaboration<\/p>\n\n\n\n
Implementation of Innovative Genomic Medicine through Single-Cell Analysis of Japanese Prostate Cancer PDX and Organoid Models<\/p>\n\n\n\n
Molecular Basis and Therapeutic Targeting of PSMA-Positive Tumor Vasculature toward a Tumor-Agnostic Treatment Strategy<\/p>\n\n\n\n
Genomic Analysis of Prostate Cancer with Pathological Features of Intraductal Carcinoma of the Prostate (IDC-P) and Its Application to Precision Medicine<\/p>\n\n\n\n
Elucidation of the Mechanisms of Neuroendocrine Prostate Cancer and Development of Novel Therapies through Integrated Single-Cell and Spatial Transcriptomic Analysis of PDX Models<\/p>\n\n\n\n
Elucidation of AR-V7 Activation Mechanisms Using a Wheat Cell-Free Protein Synthesis System and Development of Novel Therapeutics for Hormone-Resistant Prostate Cancer<\/p>\n\n\n\n
Elucidation of Prostate Cancer Progression Using State-of-the-Art Single-Cell RNA Sequencing of FFPE Tissues and Its Application to Precision Medicine
Co-investigator \/ Collaborative Research<\/em><\/p>\n\n\n\n
Targeted Drug Treatment Strategies for Rare Prostatic Ductal Carcinoma Based on Spatial Transcriptomic Analysis
Co-Investigator (Principal Investigator: Hiroaki Kobayashi)<\/em><\/p>\n\n\n\n
Elucidation of the Spatial Molecular Basis of the Antiepileptic Effects of Valaciclovir
Co-Investigator (Principal Investigator: Kenji Takechi)<\/em><\/p>\n\n\n\n
Validation of Galectin-7 as a Diagnostic Marker and Therapeutic Target in Squamous Differentiation of Urothelial Carcinoma
Co-Investigator (Principal Investigator: Shunsuke Haga)<\/em><\/p>\n\n\n\n
Elucidation of the Pathogenesis of Intraductal Carcinoma of the Prostate through Single-Cell Analysis of Prostate Cancer Spheroids
Co-Investigator (Principal Investigator: Noriyoshi Miura)<\/em><\/p>\n\n\n\nCompleted Research Grants<\/h2>\n\n\n\n
Establishment of Asian Prostate Cancer Cell Lines and Elucidation of Mechanisms Underlying Resistance to Hormonal Therapy through Single-Cell Analysis<\/p>\n\n\n\n
Development of Innovative AR-V7-Targeted Therapeutics for Hormone-Resistant Prostate Cancer Using a Wheat Cell-Free Protein Synthesis System<\/p>\n\n\n\n
Elucidation of the Pathogenesis of Intraductal Carcinoma of the Prostate (IDC-P) Using Single-Cell Analysis of PDX Models and High-Resolution Spatial Transcriptomics<\/p>\n\n\n\n
International Collaborative Research to Identify Novel Driver Genes in Prostate Cancer through Single-Cell Analysis
Research Collaborator (Principal Investigator: Tadahiko Kikugawa)<\/em><\/p>\n\n\n\n
Regulatory Mechanisms of PSMA Expression and Its Molecular Functions in Renal Cancer-Associated Vascular Endothelial Cells
Co-Investigator (Principal Investigator: Tadahiko Kikugawa)<\/em><\/p>\n\n\n\n
Elucidation of the Mechanisms Promoting PSMA-Positive Peritumoral Angiogenesis in Renal Cell Carcinoma Using Spatial Gene Expression Analysis and Development of Novel Therapeutic Strategies<\/p>\n\n\n\n
Spatial Gene Expression Analysis of Tuberous Sclerosis Complex-Associated Renal Angiomyolipoma<\/p>\n\n\n\n
Elucidation of Tumor Microenvironment-Mediated Mechanisms Underlying the Development of Neuroendocrine Prostate Cancer through Single-Cell Analysis<\/p>\n\n\n\n
Genomic Analysis of Prostate Cancer with Pathological Features of Intraductal Carcinoma of the Prostate (IDC-P) and Its Application to Precision Medicine<\/p>\n\n\n\n
Elucidation of the Mechanisms of Neuroendocrine Differentiation in Prostate Cancer Using State-of-the-Art Single-Cell RNA Sequencing and Its Application to Precision Medicine<\/p>\n\n\n\n
Elucidation of the Genetic Mechanisms Underlying the Progression of Intraductal Carcinoma of the Prostate (IDC-P) Using State-of-the-Art Single-Cell Analysis and Its Application to Precision Medicine<\/p>\n\n\n\n
Elucidation of Tumor Microenvironment-Mediated Mechanisms Underlying the Progression of Intraductal Carcinoma of the Prostate (IDC-P) Using Single-Cell Technologies and Its Application to Precision Medicine<\/p>\n\n\n\n
Elucidation of the Mechanisms of Neuroendocrine Prostate Cancer Differentiation and Development of Novel Therapies Using Single-Cell Analysis<\/p>\n\n\n\n
Single-Cell Analysis of Neuroendocrine Differentiation in Prostate Cancer Cell Lines<\/p>\n\n\n\n
Analysis of the Protein Degradation Mechanism of the Prostate Cancer Driver Gene ETV1 and Its Application to Prostate Cancer Therapy<\/p>\n\n\n\n